Avai Bio Inc (AVAI) is a pre-revenue technology company that describes itself as specializing in acquiring, creating, and developing artificial intelligence technologies and providing information technology consulting services. The company generated no revenue in either fiscal year ended March 31, 2025 or March 31, 2024. Total operating expenses were $1,532,792 for FY2025, down 28% from $2,117,182 in FY2024, driven primarily by lower employee and contractor compensation included in general and administrative expenses. The company's key disclosed assets include an acquisition called Avant! AI and a Joint Venture and License Agreement with Ainnova Tech Inc. (AINN), described as providing resources in full-stack software development, database management, data integration, project management, and cloud services. The company carries a going concern qualification from its auditors and estimates it needs approximately $10,000,000 in additional capital to fully execute its business plan. Shares trade on the OTC QB marketplace. Principal offices are listed at Sv. Stepono g. 27D-2, LT-01315 Vilnius, Lithuania, per the 10-K filed July 8, 2025.
Source: SEC 10-K, filed 2025-07-08
Industry: Services-Computer Processing & Data Preparation Peers: DecisionPoint Systems, Inc. COMPUTER TASK GROUP INC CSP Inc Research Solutions Inc Glimpse Group Inc International Business Machines Corp PFSWEB INC MicroAlgo Inc
Loading...